Gilead Sciences’s Arcellx ACLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$443M Hold
6,720,803
34.57% 2
2025
Q1
$441M Hold
6,720,803
37.32% 1
2024
Q4
$515M Buy
+6,720,803
New +$515M 33.23% 1